Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)

Ping Yen Liu; Cheng Huang Su; Feng Yu Kuo; Wen Lieng Lee; Yi Chih Wang; Wei Shiang Lin; Pao Hsien Chu; Tse Min Lu; Ping Han Lo; Cheng Han Lee; Wei Ren Lan; Chien Lung Huang; Shuji Tsukiyama; Wei Chen Yang; Li Chung Cheng; Virginia Rafael; Christian Nikolajsen; Wei Hsian Yin

doi:10.1007/s12928-021-00779-2

Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)

Ping Yen Liu, Cheng Huang Su, Feng Yu Kuo, Wen Lieng Lee, Yi Chih Wang, Wei Shiang Lin, Pao Hsien Chu, Tse Min Lu, Ping Han Lo, Cheng Han Lee, Wei Ren Lan, Chien Lung Huang, Shuji Tsukiyama, Wei Chen Yang, Li Chung Cheng, Virginia Rafael, Christian Nikolajsen, Wei Hsian Yin

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

A correction to this paper has been published: https://doi.org/10.1007/s12928-021-00779-2

Original language	English
Pages (from-to)	279-280
Number of pages	2
Journal	Cardiovascular Intervention and Therapeutics
Volume	37
Issue number	2
DOIs	https://doi.org/10.1007/s12928-021-00779-2
Publication status	Published - 2022 Apr

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s12928-021-00779-2

Fingerprint

Dive into the research topics of 'Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)'. Together they form a unique fingerprint.

Cite this

Liu, P. Y., Su, C. H., Kuo, F. Y., Lee, W. L., Wang, Y. C., Lin, W. S., Chu, P. H., Lu, T. M., Lo, P. H., Lee, C. H., Lan, W. R., Huang, C. L., Tsukiyama, S., Yang, W. C., Cheng, L. C., Rafael, V., Nikolajsen, C., & Yin, W. H. (2022). Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w). Cardiovascular Intervention and Therapeutics, 37(2), 279-280. https://doi.org/10.1007/s12928-021-00779-2

Liu, Ping Yen ; Su, Cheng Huang ; Kuo, Feng Yu et al. / Correction to : Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w). In: Cardiovascular Intervention and Therapeutics. 2022 ; Vol. 37, No. 2. pp. 279-280.

@article{6f914c7e771a4341a13fd01c9af49cca,

title = "Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)",

abstract = "A correction to this paper has been published: https://doi.org/10.1007/s12928-021-00779-2",

author = "Liu, {Ping Yen} and Su, {Cheng Huang} and Kuo, {Feng Yu} and Lee, {Wen Lieng} and Wang, {Yi Chih} and Lin, {Wei Shiang} and Chu, {Pao Hsien} and Lu, {Tse Min} and Lo, {Ping Han} and Lee, {Cheng Han} and Lan, {Wei Ren} and Huang, {Chien Lung} and Shuji Tsukiyama and Yang, {Wei Chen} and Cheng, {Li Chung} and Virginia Rafael and Christian Nikolajsen and Yin, {Wei Hsian}",

note = "Publisher Copyright: {\textcopyright} 2021, Japanese Association of Cardiovascular Intervention and Therapeutics.",

year = "2022",

month = apr,

doi = "10.1007/s12928-021-00779-2",

language = "English",

volume = "37",

pages = "279--280",

journal = "Cardiovascular Intervention and Therapeutics",

issn = "1868-4300",

publisher = "Springer Verlag",

number = "2",

}

Liu, PY, Su, CH, Kuo, FY, Lee, WL, Wang, YC, Lin, WS, Chu, PH, Lu, TM, Lo, PH, Lee, CH, Lan, WR, Huang, CL, Tsukiyama, S, Yang, WC, Cheng, LC, Rafael, V, Nikolajsen, C & Yin, WH 2022, 'Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)', Cardiovascular Intervention and Therapeutics, vol. 37, no. 2, pp. 279-280. https://doi.org/10.1007/s12928-021-00779-2

Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w). / Liu, Ping Yen; Su, Cheng Huang; Kuo, Feng Yu et al.
In: Cardiovascular Intervention and Therapeutics, Vol. 37, No. 2, 04.2022, p. 279-280.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)

AU - Liu, Ping Yen

AU - Su, Cheng Huang

AU - Kuo, Feng Yu

AU - Lee, Wen Lieng

AU - Wang, Yi Chih

AU - Lin, Wei Shiang

AU - Chu, Pao Hsien

AU - Lu, Tse Min

AU - Lo, Ping Han

AU - Lee, Cheng Han

AU - Lan, Wei Ren

AU - Huang, Chien Lung

AU - Tsukiyama, Shuji

AU - Yang, Wei Chen

AU - Cheng, Li Chung

AU - Rafael, Virginia

AU - Nikolajsen, Christian

AU - Yin, Wei Hsian

PY - 2022/4

Y1 - 2022/4

N2 - A correction to this paper has been published: https://doi.org/10.1007/s12928-021-00779-2

AB - A correction to this paper has been published: https://doi.org/10.1007/s12928-021-00779-2

UR - http://www.scopus.com/inward/record.url?scp=85106269548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106269548&partnerID=8YFLogxK

U2 - 10.1007/s12928-021-00779-2

DO - 10.1007/s12928-021-00779-2

M3 - Comment/debate

C2 - 34021881

AN - SCOPUS:85106269548

SN - 1868-4300

VL - 37

SP - 279

EP - 280

JO - Cardiovascular Intervention and Therapeutics

JF - Cardiovascular Intervention and Therapeutics

IS - 2

ER -

Liu PY, Su CH, Kuo FY, Lee WL, Wang YC, Lin WS et al. Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w). Cardiovascular Intervention and Therapeutics. 2022 Apr;37(2):279-280. doi: 10.1007/s12928-021-00779-2

Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this